PEARLITOL® CR-H by Roquette
SEE PEARLITOL® CR-H
Roquette´s new, industry-first mannitol and hydroxypropyl methylcellulose (HPMC) blend, designed for controlled release drug formulation. Leave behind wet granulation, lengthy drying times and limited flowability and unlock the potential of direct compression to create dosage forms that put patient needs first.
Discover all the functionalities here:
PEARLITOL® CR-H co-processed mannitol hydroxypropyl methylcellulose provides excipient functional properties of binder as well as controlled release to your tablets. It is a compound of mannitol and HPMC adapted to direct compression formulation.
PEARLITOL® CR-H can be used in oral tablet form in both pharmaceutical and nutraceutical application requirement controlled properties.
Read more about the new product here
See the full overview PDF about “PEARLITOL® CR-H by Roquette“ here:
(click the picture to download the brochure)
Source: Roquette website www.roquette.com
Further Downloads PEARLITOL® CR-H:
- Roquette_Quality_Specification Sheet_PEARLITOL CR-H-EXP-HYPROMELLOSE-MANNITOL_50_450500_en
- Roquette_SDS_DE_PEARLITOL CR H_000000202191_EN
See also our FAQ on Roquette Pearlitol:
